Seth Hall, MBA, RRT - phaware® interview 520
May 13, 2025
Seth Hall, MBA,
RRT, takes listeners on a journey through the past, present, and
future of inhaled therapies. Discover how these treatments have
evolved, the life-changing benefits they offer, and the
revolutionary technologies that could redefine outcomes for PAH and
PH-ILD patients.
This Special Edition episode is...
May 12, 2025
Seth Hall, MBA,
RRT, takes listeners on a journey through the past, present, and
future of inhaled therapies. Discover how these treatments have
evolved, the life-changing benefits they offer, and the
revolutionary technologies that could redefine outcomes for PAH and
PH-ILD patients.
This Special Edition episode is...
Richard Channick - phaware® interview 519
May 6, 2025
Dr. Richard Channick, dives into the evolving world within pulmonary hypertension -- interstitial lung disease (PH-ILD). He sheds light on why early diagnosis matters and how new therapies are transforming care. Learn about the latest FDA-approved treatment and what’s on the horizon.
This Special Edition episode...
May 5, 2025
Dr. Richard Channick, dives into the evolving world within pulmonary hypertension -- interstitial lung disease (PH-ILD). He sheds light on why early diagnosis matters and how new therapies are transforming care. Learn about the latest FDA-approved treatment and what’s on the horizon.
This Special Edition episode is...
Ioana Preston, MD - phaware® interview 518
Apr 29, 2025
Dr. Ioana Preston explores the emerging field of pulmonary hypertension associated with interstitial lung disease (PH-ILD). She discusses the growing recognition of PH-ILD, especially after the introduction of inhaled treprostinil as a treatment, and highlights the importance of early screening and diagnosis....